cpg glp-1 news GLP‑1 Disruption, Nestlé's Strategy Shift and Reformulation Pressure GLP-1s are Changing Diets, and

Most studies involve small participant numbers, short follow-up periods, and lack robust placebo controls, limiting the strength of conclusions

Cuando la salud es integrada, todos ganan: las personas, las organizaciones y el futuro que construyen juntos

If you have hypertension and are considering GLP-1 therapy, understanding your current blood pressure control, medication interactions, and underlying cardiovascular risk becomes critical

Among the study population, AUD co-occurred most frequently with NUD, affecting 7,769 participants (5.5%)

Participants receive structured education on each pillar throughout the year-long program, with an emphasis on gradual, sustainable habit formation

DOI: 10.1007/s11095-009-0045-6 DailyMed